Markets · 1 sources covering this

Sensex falls over 300 points, Nifty below 24,550 as oil prices rise. What lies ahead?

On Tuesday, Indian stock markets experienced a downturn influenced by increasing oil prices and escalating tensions in the Middle East. Nevertheless, the broader markets displayed resilience as small and midcap indices thrived. Foreign institutional investors found encouragement in favorable Q1 outcomes and a stable rupee, suggesting that the market could maintain its strength with a slight upward trend. Strong domestic consumption is projected to support earnings growth through FY27.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

Economic TimesLean R·1h ago
Sensex falls over 300 points, Nifty below 24,550 as oil prices rise. What lies ahead?
On Tuesday, Indian stock markets experienced a downturn influenced by increasing oil prices and escalating tensions in the Middle East. Nevertheless, the broader markets displayed resilience as small and midcap indices thrived. Foreign institutional investors found encouragement in favorable Q1 outcomes and a stable rupee, suggesting that the market could maintain its strength with a slight upward trend. Strong domestic consumption is projected to support earnings growth through FY27.
Read at Economic Times →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/1e5276876d522f6c4048b5674e8468e7367d2a91"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Sensex falls over 300 points, Nifty below 24,550 as oil prices rise. What lies ahead?"></iframe>

Sensex falls over 300 points, Nifty below 24,550 as oil prices rise. What lies ahead?

How 1 sources are covering this

Sensex falls over 300 points, Nifty below 24,550 as oil prices rise. What lies ahead?

More from Markets

Info Edge shares jump 4% after strong Q1 show. What Nomura, Nuvama and other brokerages expect next

Nifty price-to-book valuation hits pre-Covid level. Why the index is still not cheap

Gland Pharma shares rally 12% after Q1FY27 profit jumps 47% YoY. Should you buy, sell or hold?

Paytm shares recover 410% from 2024 low, but will long-awaiting IPO investors finally see redemption?

Reader

Trust & legal

Across the network